vaccine News

The Virginia House of Delegates has voted to repeal the law requiring girls to receive the human papillomavirus vaccine.

Modified strain of yeast paves way for new industrial vaccine production process

Vincent G. Brichard, SVP at GlaxoSmithKline to speak at Immunotherapeutics Partnering conference Jan 2012, San Diego, CA

Piribo, the online destination for Pharma intelligence, has added a new report.

Scientists from The University of Edinburgh created a vaccine for Malaria, which has now been further developed after a study revealed a fundamental protein in the blood of African children...

Over two million people in India die due to chronic liver disease. Of them, 15% are infected with the Hepatitis C virus (HCV) while 45 % die due to the Hepatitis B virus (HBV).

An Epstein-Barr virus (EBV) vaccine in the early phases of development may prove able to prevent infectious mononucleosis and EBV-associated cancers.

The Center for the Biology of Chronic Disease (CBCD) has learned that there is a shortage of Hepatitis B (HBV) vaccine in Nagpur city, India.

Netscribes (India) Pvt. Ltd., launches its Syringes & Needles Market in India Report 2011 covering one of the emerging markets in India with strong growth prospects . It is a part of Netscribes’ Healthcare Series reports.

The Center for the Biology of Chronic Disease (CBCD) congratulates the success of Agneus, Inc.’s HerpV vaccine study.

New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects

The Center for the Biology of Chronic Disease (CBCD) urges the public to take precautions against contracting the flu and vaccinate themselves and family members this flu season.

BiondVax Announces Receipt of IRB Ethics (“Helsinki”) Committee Approvals for the Initiation of Second Phase II Clinical Trial for Universal Influenza Vaccine. The trial will start in October 2011 with 120 participants over the age of 65.

The biotech market in South Korea is forecasted to grow at a CAGR of around 35% during 2010-2013, says RNCOS in its latest research study.

This exciting event will bring together some of the leading TB researchers in the world to discuss the latest development in TB therapy.

Hospital gearing up to make sure employees get flu shots

The South Korean biotech industry is expected to grow at a CAGR of around 35% during 2010-2013, thereby contributing majorly to the Asia Pacific biotech market, says RNCOS in its latest research.

The Best Veterinarian Care For Your Pets!

Asthma is one of many diseases which may see a vaccine product within this decade, according to healthcare market research firm Kalorama Information's report What’s Next in Vaccines?

ROTAVAC® expecting India licensure during 2014 will be sold to global public markets at a price of US $ 1.0

The Asia Pacific biotech market is expected to grow at a CAGR of around 19% during 2010-2013 on the back of demographic factors and increasing investments in the industry, says RNCOS.

BiondVax Pharmaceuticals Ltd. is pleased to announce that the company's Chief Scientific Officer, Dr. Tamar Ben-Yedidia, will present the results of the Phase IIa clinical trial on the universal flu vaccine at the 2011 BIO International Convention.

There is a significant amount of vaccine clinical trials going on in Asia, according to healthcare market research publisher Kalorama Information's research report Asian Vaccine Markets.

Recently published research from Datamonitor, "Sanofi-Aventis: PharmaVitae Profile", is now available at Fast Market Research

New evidence suggests vaccinated children and adults suffer from significantly more ADHD, neurologic disorders, autism, asthma, allergies, respiratory infections and many other potentially serious illnesses, including cancer.

Today, Inovio Pharmaceuticals reports long-term immune responses from therapeutic cervical dysplasia and cancer DNA vaccine. Mark Bagarazzi, M.D., Chief Medical Officer, will speak at CHI's Clinical Development of Vaccines conference.

Vaccine leaders to convene at four co-located conferences on August 16-18, 2011 in Cambridge, Mass.

New Healthcare research report from Business Monitor International is now available from Fast Market Research

Recently published research from Business Monitor International, "Saudi Arabia Pharmaceuticals & Healthcare Report Q2 2011", is now available at Fast Market Research

OTIS Joins The Effort To Raise Awareness Of Meningitis Prevention

Fast Market Research recommends "Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available

New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

Swine flu infections across the globe; Three options available to protect against H1N1 swine flu

New Healthcare market report from GlobalData: "Hester Biosciences Limited (524669) - Financial and Strategic Analysis Review"

New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

New Pharmaceuticals market report from Datamonitor: "Pipeline and Commercial Insight: Pneumococcal and Meningococcal Vaccines"

New Healthcare research report from Business Monitor International is now available from Fast Market Research

Regulatory Officials recently made huge advances in Artificial Immune Function Technology Transitions for Assessing Vaccine and Biothreats Efficacy; whereby Knight Officials considered the legislative impact.

New Pharmaceuticals market report from GlobalData: "Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2017"

BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company developing a Universal Influenza Vaccine, today announced that it has raised $1.25 million under its Standby Equity Distribution Agreement (SEDA) with YA Global Investments L.P.

Dr. Tamar Ben-Yedidia will be presenting at the Influenza Congress USA next week in Washington, D.C. BiondVax is currently in Phase IIa clinical trials (human subjects) for its Universal Influenza Vaccine.

The Prostate Cancer Therapeutics Market was Driven by the Growth in Patient Volume and Annual Cost of Hormone-refractory Prostate Cancer Therapy

Miles For Hope, a Clearwater charity, will be the recipient of proceeds from a fundraising challenge set to raise critically needed awareness and funding of brain tumors

Breast cancer accounts for approximately 12% of all cancers worldwide. In the U.S. more than 200,000 people develop breast cancer each year, with more than 95% of these women.

Bharatbook added a new report on "Global Vaccine Market Forecast to 2012" which gives extensive research and objective analysis of the vaccine market in key countries of the world. By RNCOS.

Dr. Tamar Ben-Yedidia will be speaking at the upcoming World Vaccine Congress in Lyon, France on October 4, 2010. She will be updating the congress on the company's progress and upcoming Phase II trials starting in October.

ResearchInChina, the vertical portal for Chinese business intelligence, announces the release of a new report - China Vaccine Industry Report, 2009-2010. For more information, please contact us at report@researchinchina.com or at 86-10-82600828.

To meet the demand for this year's flu season, specially trained and certified JEWEL-OSCO pharmacists are available to administer the flu vaccine at nearly all JEWEL-OSCO pharmacies.

Drug delivery has become an important focus of the industry. Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena.

The FDA is to assess the feasibility of Glythera technology in developing antigenic glycoproteins as synthetic conjugate vaccines.